This course includes the webinar and SAM credit


In this webinar, Dr. Tracy George will discuss updates in the classification of myeloproliferative neoplasms, also including eosinophilic neoplasms with recurring mutations, and mastocytosis. This includes new criteria for accelerated phase (response-to-TKI criteria) in chronic myeloid leukemia, WHO 2016 criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis, as well as eosinophilic neoplasms with and without recurring mutations. Updates in the diagnosis of mastocytosis, now its own chapter again in the WHO 2016 classification, will also be explained.

A collaborative educational event presented by Association for Molecular Pathology (AMP) and Society for Hematopathology (SH).


Speaker: Tracy I. George, MD

Host: Mark D. Ewalt, MD

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: March 1, 2021

Maximum SAM credit available: 1.0


How to Claim Credit

To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 75% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

SAM Credit

This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

* You may not submit SAMs and CME/CMLE credit for the same content.


You might also be interested in:

 

Note: Join the AMP Family to purchase this content for a deep discount!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

 

 

 

 

Course Information
Course Date:
March 01, 2018
Course Objectives
  • Describe provisional criteria for response-to-tyrosine kinase inhibitors in chronic myeloid leukemia.
  • Recognize neoplastic mast cells in bone marrow.
  • Follow a diagnostic algorithm for eosinophilia.
  • Discuss updated pathologic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
WHO Update 2016: Myeloproliferative Neoplasms (CE Available)
Speaker Information
Tracy I. George MD  [ view bio ]
Individual topic purchase: Selected
American Board of Pathology
Self-Assessment Module: 1.00
Products
George Presentation (+Sam)
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $215.00